Resistance to apoptosis in human cells conferred by telomerase function and telomere stability

Molecular Carcinogenesis

Volumn 25, Issue 4, 1999, Pages 241-248

  Holt, Shawm E ^a   Glinsky, Vladislav V ^b   Ivanova, Anna B ^c   Glinsky, Gennadi V ^b,c,d  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c MetaStat Inc   (United States)

^d SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

Apoptosis; Cancer; Telomerase activity; Telomeres

Indexed keywords

CASPASE; ENDONUCLEASE; INTERLEUKIN 1BETA CONVERTING ENZYME; TELOMERASE;

APOPTOSIS; ARTICLE; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; DIPLOIDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INDUCTION; GENETIC STABILITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELOMERE;

APOPTOSIS; CELL AGING; CELL LINE, TRANSFORMED; HUMANS; TELOMERASE; TELOMERE;

EID: 0032781973     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199908)25:4<241::AID-MC2>3.0.CO;2-9     Document Type: Article

References (46)

1. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;7:614-636.
2. de Lange T, Shiue L, Myers RM, et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990; 10:518-526.
3. Greider CW. Telomeres, telomerase and senescence. Bioessays 1990;12:363-369.
4. Harley CB. Telomere loss: Mitotic clock or genetic time bomb? Mutat Res 1991;256:271-282.
5. Harley CB, Fletcher AB, Greider CW. Telomeres shorten during aging. Nature 1990;345:458-460.
6. Watson JD. Origin of concatameric T4 DNA. Nature 1972; 239:197-201.
7. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymatic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol 1973;41:181-190.
8. Wright WE, Pereira-Smith OM, Shay JW. Reversible cellular senescence: Implication for a two-stage model for the immortalization of normal human diploid fibroblasts. Mol Cell Biol 1989;9:3088-3092.
9. Allsopp RC, Vaziri H, Patterson C, et al. Telomere length predicts replicative capacity of human fibroblasts. Proc Natl Acad Sci USA 1992;89:10114-10118.
10. Levy MZ, Allsopp RC, Futcher AB, Greider CW, Harley CB. Telomere end-replication problem and cell aging. J Mol Biol 1992;225:951-960.
11. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991;196:33-39.
12. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
13. Shay JW, Bacchetti SA. Survey of telomerase activity in human cancer. Eur J Cancer 1997;5:787-791.
14. Raff MC. Social control on cell survival and cell death. Nature 1994;356:397-400.
15. Willams GT, Smith CA. Molecular regulation on apoptosis: Genetic control on cell death. Cell 1993;74:777-779.
16. Wyllie AH, Kerr JFR, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980;68:251-306.
17. Glinsky GV, Price JE, Glinsky W, Mossine VV, Kiriakova G, Metcalf JB. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines. Cancer Res 1996; 56:5319-5324.
18. Glinsky GV, Glinsky VV, Ivanova AB, Heuser JN. Apoptosis and metastasis: Increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Lett 1997;115: 185-193.
19. Bodnar AG, Ouellette M, Frolkis M, et al. Extension of lifespan by introduction of telomerase into normal human cells. Science 1998;279:349-352.
20. Wright WE, Brasiskyte D, Piatyszek MA, Shay JW. Experimental elongation of telomeres extends the lifespan of immortal x immortal cell hybrids. EMBO J 1996;15: 1734-1741.
21. Glinsky GV, Glinsky VV. Apoptosis and metastasis: A superior resistance of metastatic cancer cells to programmed cell death. Cancer Lett 1996;101:43-51.
22. Piatyszek MA, Kim NW, Weinrich SL, et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods in Cell Science 1995;17:1-15.
23. Holt SE, Norton JC, Wright WE, Shay JW. Comparison of the telomeric repeat amplification protocol (TRAP) to the new TRAP-eze telomerase detection kit. Methods in Cell Science 1996;18:237-248.
24. Wang E. Regulation of apoptosis resistance and ontogeny of age-dependent diseases. Exp Gerontol 1997;32: 471-484.
25. Bryan TM, Engelzou A, Gupta J, Bacchetti S, Reddel RR. Telomere elongation in immortal cells without detectable telomerase activity. EMBO J 1995;14:4240-4248.
26. Murnane JP, Sabatier L, Marder BA, Morgan WF. Telomere dynamics in an immortal human cell line. EMBO J 1994; 13:4953-4962.
27. Harley CB, Kim NW, Prowse KR, et al. Cell immortality, telomerase and cancer. Cold Spring Harb Symp Quant Biol 1994;307-315.
28. Wyllie AH. Glucocoriticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-556.
29. Arends MJ, McGregor AH, Toft NJ, Brown EJH, Wyllie AH. Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability. Br J Cancer. 1993;68: 1127-1133.
30. McConkey DJ, Chandra J, Wright S, et al. Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of Bcl-2 and Bax. J Immunol 1996;156:624-2630.
31. Casciola-Rosen LA, Miller DK, Anhalt GJ, Rosen A. Specific cleavage of the 70-kDa protein component of small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem 1994;269:30757-30760.
32. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 1994;269: 30761-30764.
33. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. Cleavage of poly-(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 1994; 371:346-347.
34. Tewari M, Quan LT, O'Rourke K, et al. Yama/CPP32B, a mammalian homolog of CED-3, is a crm-inhibitable protease that cleaves the death substrate poly-(ADP-ribose) polymerase. Cell 1995;81:801-809.
35. Wright WE, Shay JW. Telomere positional effects and the regulation of cellular senescence. Trends Genet 1992;8: 193-197.
36. Morales CP, Holt SE, Ouellette M, et al. Lack of cancer-associated changes in human fibroblasts after immortalization with telomerase. Nat Genet 1999;21:115-118.
37. Jiang Z-R, Jimenez G, Chang E, et al. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 1999;21: 111-114.
38. Harrington L, Zhou W, McPhail T, et al. Human telomerase contains evolutionary conserved catalytic and structural subunits. Genes Dev 1997;11:3109-3115.
39. Lingner J, Hughes TR, Shevchenko A, Mann M, Lundblad V, Cech TR. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 1997;276:561-567.
40. Counter CM, Meyerson M, Eaton EN, Weinberg RA. The catalytic subunit of yeast telomerase. Proc Natl Acad Sci USA 1997;94:9202-9207.
41. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and humans. Science 1997;277:955-959.
42. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 1997;90:785-795.
43. Chong L, van Steensel B, Broccoli D, et al. A human telomeric protein. Science 1995;270:1663-1667.
44. Selvakumaran M, Lin HK, Sjin RT, Reed JC, Leiberman DA, Hoffman B. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor B1-induced apoptosis of myeloid leukemia cells. Mol Cell Biol 1994;14:2352-2360.
45. Sala A, Casella I, Grasso L, et al. Apoptosis response to oncogenic stimuli: Cooperative and antagonistic interactions between c-myb and the growth suppressor p53. Cancer Res 1996;56:1991-1996.
46. Glinsky GV, Glinsky VV. A hypothesis for telomere-dependent control of apoptosis. In: Glinsky GV, editor. Failure of apoptosis and cancer metastasis. Berlin: Springer-Verlag; 1998. p 111-141.